Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.33 |
| ▸ | RAPGEF4 | Q8WZA2 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | CASP7 | P55210 | 1/20 | 0.33 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.32 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3593411 | 0.81 | GABRA1 (0.41) | ALDH1A1HIF1ARAPGEF4HSD17B10CYP1A2 | |
| SCHEMBL6923614 | 0.79 | SHBG (0.36) | ALDH1A1HIF1ARAPGEF4HSD17B10CYP1A2 | |
| SCHEMBL2293898 | 0.79 | GABRA1 (0.44) | ALDH1A1HIF1AALOX15AMY1AHSPA5 | |
| SCHEMBL16248904 | 0.77 | CYP3A4 (0.39) | ALDH1A1HIF1AHSD17B10CYP1A2ALOX15 | |
| SCHEMBL6825426 | 0.76 | ALDH1A1 (0.38) | ALDH1A1HIF1AHSD17B10CYP1A2ALOX15 | |
| SCHEMBL156826 | 0.76 | RAPGEF4 (0.45) | ALDH1A1RAPGEF4HSD17B10CYP1A2KDM4E | |
| SCHEMBL14682851 | 0.74 | ALDH1A1 (0.46) | ALDH1A1HIF1AHSD17B10AMY1AHSPA5 | |
| SCHEMBL20577412 | 0.74 | RAPGEF4 (0.32) | RAPGEF4KDM4EL3MBTL1 | |
| SCHEMBL7456451 | 0.74 | RAPGEF4 (0.39) | ALDH1A1RAPGEF4ALOX15L3MBTL1 | |
| SCHEMBL2289174 | 0.74 | ALDH1A1 (0.39) | ALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230374038-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS (SAN DIEGO) LLC | 2023-11-23 | — | — | US | disclosed |
| EP-2149545-B1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2016-10-05 | — | — | EP | disclosed |
| US-7994367-B2 | Method for producing benzaldehyde compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-08-09 | — | — | US | disclosed |
| US-20100210879-A1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-08-19 | — | — | US | disclosed |
| EP-2149545-A1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2010-02-03 | — | — | EP | disclosed |
| US-6210863-B1 | ORTHO-SUBSTITUTED ON AT LEAST TWO ARYL RADICALS, ADDITION POLYMERIZATION | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-04-03 | — | — | US | disclosed |
| US-6057078-A | PHOTOGRAPHY | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2000-05-02 | — | — | US | disclosed |
| US-5952152-A | POLYMERIZABLE MIXTURE COMPRISING AT LEAST ONE ETHYLENICALLY UNSATURATED COMPOUND AND AN ANIONIC BORON COMPOUND ACTIVATOR | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1999-09-14 | — | — | US | disclosed |
| US-5807905-A | POLYMERIZATION OF UNSATURATED COMPOUNDS | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-09-15 | — | — | US | disclosed |
| EP-0520235-B1 | Method of preparing 2-bromo-4,6-dinitromesitylene | DU PONT (US) | 1995-03-29 | — | — | EP | disclosed |
| EP-0520235-A2 | Method of preparing 2-bromo-4,6-dinitromesitylene | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-12-30 | — | — | EP | disclosed |
| US-5118880-A | Mixing fuming sulfuric acid with bromomesitylene, then concentrated nitric acid | E. I. DU PONT DE NEMOURS & CO. (US) | 1992-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230374038-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | CFTR, SCNN1G, SCNN1B | ALDH1A1 4121/4885HIF1A 3815/4885RAPGEF4 179/4885 |
| US-20100210879-A1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | NQO1, C9, TRPA1 | ALDH1A1 83/4885HIF1A 2987/4885RAPGEF4 2504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.